(:NUVA)
Business Focus: N/A
Jul 24, 2023 07:00 am ET
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results
SAN DIEGO, July 24, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that it will release its second quarter 2023 results on Wednesday, August 2, 2023, after the close of the market.
May 10, 2023 04:05 pm ET
NuVasive Announces First Quarter 2023 Financial Results
–Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis––U.S. cervical delivers sixth consecutive quarter of greater than 20% growth, driven by C360 and the Simplify Cervical Disc–
May 04, 2023 07:00 am ET
NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results
SAN DIEGO, May 4, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2023 results on Wednesday, May 10, 2023, after the close of the market.
Apr 27, 2023 07:08 pm ET
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common...
Apr 27, 2023 11:30 am ET
NuVasive Shareholders Approve Merger Agreement with Globus Medical
SAN DIEGO, April 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that at the special meeting of shareholders held earlier today, its shareholders voted to approve the adoption of the Company's merger agreement with Globus Medical (NYSE: GMED). As previously announced, under the terms of the merger agreement, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive comm
Apr 18, 2023 09:50 am ET
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FOCS, PTRS, INFI, NUVA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Focus Financial Partners Inc. (NASDAQ:...
Apr 17, 2023 02:22 pm ET
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO
NEW YORK, April 17, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Apr 17, 2023 01:57 pm ET
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
SAN DIEGO, April 17, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that proxy advisory firm, Glass Lewis & Co., LLC ("Glass Lewis"), recommends that NuVasive shareholders vote "FOR" the shareholder proposal to adopt the merger agreement with Globus Medical (NYSE: GMED) at NuVasive's upcoming special meeting of shareholders ("the special meeting") scheduled for April 27, 2023. Only holders of record of NuVasive common stock as
Apr 14, 2023 02:21 pm ET
Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical
SAN DIEGO, April 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that leading independent proxy advisory firm Institutional Shareholder Services ("ISS") recommends that NuVasive shareholders vote "FOR" the shareholder proposal to adopt the merger agreement with Globus Medical (NYSE: GMED) at NuVasive's upcoming special meeting of shareholders ("the special meeting") scheduled for April 27, 2023. Only holders of record of NuVasi
Apr 13, 2023 12:49 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, OSH, SUMO
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ:...
Apr 12, 2023 05:14 pm ET
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – TIG, PTRS, NUVA, CVT
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Apr 11, 2023 01:42 pm ET
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVA
NEW YORK, April 11, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Apr 11, 2023 07:00 am ET
NuVasive to Participate in Upcoming Global Spine Conferences
SAN DIEGO, April 11, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its continued participation at various global conferences throughout April and May.
Apr 06, 2023 11:35 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, OSH, MAXR
NEW YORK, April 6, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Apr 05, 2023 04:00 pm ET
SHAREHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – NUVA, CSII, ANGN, AGFS
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Mar 30, 2023 09:43 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TA, SUMO, NUVA, TCRR
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: TravelCenters of America Inc. (NASDAQ:...
Mar 29, 2023 04:35 pm ET
ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – ANGN, CSII, AGFS, NUVA
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Mar 29, 2023 03:13 pm ET
NUVASIVE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED). Under the terms of the proposed transaction, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Mar 28, 2023 11:50 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, SUMO, OSH
NEW YORK, March 28, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Mar 24, 2023 08:52 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, FOCS, ROCC, NUVA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Partners Bancorp (NASDAQ: PTRS)’s sale...
Mar 23, 2023 03:04 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, ARGO, SUMO, NUVA
NEW YORK, March 23, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Mar 22, 2023 03:50 pm ET
STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – NUVA, ANGN, AGFS, CSII
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Mar 20, 2023 07:00 am ET
NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients
SAN DIEGO, March 20, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its Precice all-internal limb lengthening solution to include pediatric patients*. The expanded clearance extends the clinical benefits of Precice to a wider range of patients.
Mar 16, 2023 09:08 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, CSII, NUVA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Angion Biomedica Corp. (NASDAQ:...
Mar 15, 2023 05:14 pm ET
SHAREHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – AGFS, NUVA, CSII, ANGN
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and...
Mar 14, 2023 11:55 am ET
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSII, NUVA, SUMO
NEW YORK, March 14, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Mar 14, 2023 07:00 am ET
NuVasive to Participate in Upcoming Spine Society Annual Conferences
SAN DIEGO, March 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its continued participation at the 2023 Spine Summit held March 16-19 in Miami and the International Meeting on Advanced Spine Techniques (IMAST) held March 22-25 in Dublin.
Mar 13, 2023 07:00 am ET
NuVasive Celebrates 20-Year Milestone of the XLIF Procedure
NuVasive commemorates industry-defining innovation in the lateral procedural segment
Mar 09, 2023 09:26 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, OSH, ANGN, NUVA
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Mid Penn Bancorp, Inc. (NASDAQ: MPB)’s...
Mar 08, 2023 04:00 pm ET
SHAREHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – NUVA, JNCE, ROCC, TCRR
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Feb 27, 2023 03:10 pm ET
NuVasive to Participate in Upcoming Investor Conferences
SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will participate in upcoming investor conferences and will be joined by Globus Medical management to discuss the two companies' recent merger announcement and other business topics:
Feb 22, 2023 05:16 pm ET
ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – NBTB, MPB, CSII, NUVA
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Feb 22, 2023 10:33 am ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO)
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Feb 21, 2023 06:00 am ET
NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty
Attrax Putty is now on-label for use with cervical Modulus interbody implants
Feb 19, 2023 08:34 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, ALR
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ:...
Feb 17, 2023 08:00 pm ET
STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – SUMO, CSII, NUVA, FMIA
Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Feb 14, 2023 01:39 pm ET
Moore Kuehn Encourages ARGO, OSH, CSII, and NUVA Investors to Contact Law Firm
Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek...
Feb 14, 2023 11:04 am ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO)
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Feb 13, 2023 06:42 pm ET
ALERT: The M&A Class Action Firm Announces the Investigation of NuVasive, Inc. - NUVA
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating NuVasive, Inc. (NASDAQ: NUVA), relating to its proposed sale to Globus Medical, Inc. Under the terms of the agreement, NUVA shareholders are expected to receive 0.75 shares of Globus per share they own. Click here for more information: ht
Feb 13, 2023 11:06 am ET
NUVASIVE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED). Under the terms of the proposed transaction, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Feb 12, 2023 08:46 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NUVA, SUMO
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: NuVasive, Inc. (NASDAQ: NUVA)’s sale...
Feb 11, 2023 10:37 pm ET
Moore Kuehn Encourages OSH, NUVA, CSII, and ARGO Investors to Contact Law Firm
NEW YORK, Feb. 11, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:
Feb 11, 2023 08:11 pm ET
Lifshitz Law PLLC Announces Investigations of SUMO, GMED, NUVA, and CSII
Sumo Logic, Inc. (NASDAQ: SUMO) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SUMO to affiliates of Francisco Partners for $12.05 per share in cash. If you are a SUMO...
Feb 10, 2023 10:17 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SUMO, NUVA, GMED
NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Feb 09, 2023 06:01 pm ET
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of NuVasive, Inc.
NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by NuVasive, Inc. (NASDAQ: NUVA) and its board of directors concerning the proposed acquisition of the company by Globus Medical, Inc. (NYSE: GMED). Stockholders will receive 0.75 shares of Globus Medical Class A common stock for each share of NuVasive, Inc. stock that they hold. The transaction is valued at approximately $3.1 billion and is expected to close in mid-2023.
Feb 09, 2023 10:15 am ET
Shareholder Alert: Ademi LLP investigates whether NuVasive, Inc. has obtained a Fair Price in its transaction with Globus Medical
MILWAUKEE, Feb. 9, 2023 /PRNewswire/ -- Ademi LLP is investigating NuVasive (NASDAQ: NUVA) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical.
Feb 09, 2023 10:10 am ET
NUVA Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Merger of NuVasive With Globus Medical
The law firm of Wohl & Fruchter LLP is investigating whether the directors of NuVasive, Inc. (Nasdaq: NUVA) (“NuVasive”) acted in the best interests of NuVasive shareholders in approving the merger of NuVasive with Globus Medical, Inc. (“Globus”)...
Feb 09, 2023 09:08 am ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO)
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Feb 09, 2023 08:01 am ET
NUVA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NuVasive, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of NuVasive, Inc. (NASDAQ: NUVA) to Globus Medical, Inc. for 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock is fair to NuVasive shareholders.
Feb 09, 2023 06:00 am ET
Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care
Capitalizes on complementary global commercial organizations and accelerates Globus Medical's and NuVasive's globalization strategies to increase customer reach and deepen surgeon relationships
Jan 30, 2023 06:00 am ET
NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2022 Results
SAN DIEGO, Jan. 30, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its fourth quarter and full-year 2022 results on Wednesday, February 22, 2023, after the close of the market.
Dec 12, 2022 06:00 am ET
NuVasive to Participate in the 41st Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 12, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 12, 2023 at 7:30 a.m. PT.
Dec 02, 2022 06:37 pm ET
Allegro Microsystems and CubeSmart Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
NEW YORK, Dec. 2, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 19 to coincide with the quarterly rebalance:
Nov 17, 2022 06:00 am ET
NuVasive Showcases Latest Innovation in Virtual Global Event
SAN DIEGO, Nov. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, held a virtual event yesterday showcasing the Company's latest innovation across its market-leading 360 portfolios.
Nov 16, 2022 06:00 am ET
NuVasive to Participate in Piper Sandler 34th Annual Healthcare Conference
SAN DIEGO, Nov. 16, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate in the Piper Sandler 34th Annual Healthcare Conference in New York on Wednesday, November 30, 2022 at 12:30 p.m. ET.
Nov 14, 2022 06:00 am ET
NuVasive to Sponsor and Participate at the Cervical Spine Research Society 50th Annual Meeting
SAN DIEGO, Nov. 14, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Cervical Spine Research Society (CSRS) as a diamond sponsor and will attend the CSRS 50th Annual Meeting held November 16 to 19 in San Diego.
Nov 09, 2022 03:05 pm ET
NuVasive Announces Third Quarter 2022 Financial Results
– Net sales grew 9.0% as reported, 12.9% on a constant currency basis –
Nov 07, 2022 06:00 am ET
NuVasive Launches Tube System and Excavation Micro for Posterior Spine Surgery
SAN DIEGO, Nov. 7, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the commercial launch of the NuVasive Tube System (NTS) and Excavation Micro, a new minimally invasive surgery (MIS) system that provides comprehensive solutions for both TLIF and decompression. These additions expand the Company's access and instrumentation technology offerings within the NuVasive P360 portfolio.
Oct 25, 2022 07:00 am ET
NuVasive Announces Conference Call and Webcast of Third Quarter 2022 Results
SAN DIEGO, Oct. 25, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter financial results on Wednesday, November 9, 2022, after the market close.
Oct 17, 2022 07:00 am ET
NuVasive to Sponsor and Participate at EUROSPINE 2022
SAN DIEGO, Oct. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with EUROSPINE as a gold sponsor and will attend EUROSPINE 2022 held October 19 to 21 in Milan.
Sep 29, 2022 07:00 am ET
NuVasive Announces Agenda for Investor Day 2022
SAN DIEGO, Sept. 29, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, has announced the planned agenda for the Company's Investor Day 2022, which will be hosted at the NuVasive West Coast Experience Center in San Diego on Thursday, October 6, 2022, with presentations beginning at 9:00 a.m. PT.
Sep 28, 2022 07:00 am ET
NuVasive Launches Reline Cervical for Posterior Cervical Fusion as Part of the C360 Portfolio
The cervical solution marks the completion of the NuVasive Reline fixation portfolio for complex deformity from occiput to sacrum
Sep 26, 2022 07:00 am ET
NuVasive to Sponsor and Participate at Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum '22
SAN DIEGO, Sept. 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Society for Minimally Invasive Spine Surgery (SMISS) as a sponsor and will attend the SMISS Annual Forum '22 held September 29 to October 1, 2022 in Las Vegas.
Sep 12, 2022 07:00 am ET
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
SAN DIEGO, Sept. 12, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Scoliosis Research Society (SRS) as a double diamond sponsor and will attend the 57th Annual Meeting held September 14-17, 2022 in Stockholm, Sweden.
Sep 07, 2022 08:30 am ET
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council
BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennekens, executive...
Aug 23, 2022 07:00 am ET
NuVasive to Participate in Upcoming Investor Conferences
SAN DIEGO, Aug. 23, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following investor conferences:
Aug 09, 2022 04:10 pm ET
NuVasive Announces Departure of Chief Commercial Officer
SAN DIEGO, Aug. 9, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the resignation of Massimo Calafiore, executive vice president and chief commercial officer, effective August 31, 2022, to become the chief executive officer of a privately-held, orthopedics technology company. Upon Mr. Calafiore's resignation, his responsibilities will be reallocated among current members of management while the Company aligns its commercial struct
Aug 03, 2022 04:05 pm ET
NuVasive Announces Second Quarter 2022 Financial Results
–Strong year-over-year net sales growth, driven by new product introductions–
Jul 28, 2022 07:00 am ET
NuVasive to Participate in Canaccord Genuity 42nd Annual Growth Conference
SAN DIEGO, July 28, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Financial Officer Matt Harbaugh will participate in the Canaccord Genuity 42nd Annual Growth Conference in Boston on Thursday, August 11, 2022 at 1:30 p.m. ET.
Jul 26, 2022 07:00 am ET
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions
Jul 18, 2022 07:00 am ET
NuVasive Announces Conference Call and Webcast of Second Quarter 2022 Results
SAN DIEGO, July 18, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its second quarter results on Wednesday, August 3, 2022, after the close of the market.
Jun 29, 2022 04:10 pm ET
NuVasive Opens Singapore Experience Center for Asia-Pacific region
New center supports the Company's globalization efforts through increased surgeon training and education in Asia-Pacific region
May 04, 2022 04:05 pm ET
NuVasive Announces First Quarter 2022 Financial Results
– Strong year-over-year net sales growth, driven by new product introductions and International sales –– Company raises lower end of full-year 2022 financial guidance range –
Apr 26, 2022 07:00 am ET
NuVasive Specialized Orthopedics Surpasses 100 Peer-Reviewed Publications of the Precice System for Limb Lengthening
SAN DIEGO, April 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) today announced a milestone of more than 100 peer-reviewed publications of the Precice® System (Precice) for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™ (NSO). The Precice System is an intramedullary nail that once implanted, utilizes an External Remote Controller (ERC) to non-invasively lengthen the limb.
Apr 21, 2022 07:00 am ET
NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine
Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF
Apr 20, 2022 04:10 pm ET
NuVasive Announces Conference Call and Webcast of First Quarter 2022 Results
SAN DIEGO, April 20, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter results on Wednesday, May 4, 2022, after the close of the market.
Feb 23, 2022 03:10 pm ET
NuVasive Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Outlook
SAN DIEGO, Feb. 23, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended December 31, 2021.
Feb 22, 2022 06:00 am ET
NuVasive to Participate in 42nd Annual Cowen Healthcare Conference
SAN DIEGO, Feb. 22, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will virtually present at the 42nd Annual Cowen Healthcare Conference on Tuesday, March 8, 2022 at 8:10 a.m. PT / 11:10 a.m. ET.
Feb 08, 2022 06:00 am ET
NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2021 Results
SAN DIEGO, Feb. 8, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its fourth quarter and full year 2021 results on Wednesday, February 23, 2022, after the close of the market.
Jan 31, 2022 03:10 pm ET
NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer
SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Andrew (Drew) C. Morton as senior vice president and chief human resources officer (CHRO) effective February 7, 2022.
Jan 05, 2022 06:00 am ET
NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company's Thoracolumbar Interbody Portfolio
SAN DIEGO, Jan. 5, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company received U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax® Putty with its comprehensive thoracolumbar interbody portfolio for spine surgery. Attrax Putty is the first synthetic biologic to receive indications for use in interbody fusions of the thoracolumbar spine.
Dec 28, 2021 06:00 am ET
NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 28, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will virtually present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 12:00 p.m. PT / 3:00 p.m. ET.
Nov 18, 2021 06:00 am ET
NuVasive to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
SAN DIEGO, Nov. 18, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive CEO J. Christopher Barry will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.
Nov 09, 2021 03:10 pm ET
NuVasive Announces Third Quarter 2021 Financial Results
SAN DIEGO, Nov. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2021.
Nov 01, 2021 07:00 am ET
NuVasive to Present at Credit Suisse 30th Annual Healthcare Conference
SAN DIEGO, Nov. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will virtually present at the Credit Suisse 30th Annual Healthcare Conference on Thursday, November 11, 2021 at 8:20 a.m. PT / 11:20 a.m. ET.
Oct 28, 2021 07:00 am ET
NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Annual Forum '21
SAN DIEGO, Oct. 28, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will sponsor and participate in the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum '21 in Las Vegas from October 28 to 30, 2021.
Oct 27, 2021 07:00 am ET
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
SAN DIEGO, Oct. 27, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the upcoming release of a cutting-edge virtual reality (VR) training module for the NuVasive X360® system to complement its market-leading Clinical Professional Development (CPD) program.
Oct 25, 2021 07:00 am ET
NuVasive Announces Conference Call and Webcast of Third Quarter 2021 Results
SAN DIEGO, Oct. 25, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter 2021 earnings results on Tuesday, November 9, 2021, after the close of the market.
Oct 14, 2021 07:00 am ET
NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
SAN DIEGO, Oct. 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of the Cohere® TLIF-O implant and upcoming launch of the Cohere TLIF-A implant planned for later in the fourth quarter. With these additions to its Advanced Materials Science™ (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery.1
Sep 30, 2021 07:00 am ET
NuVasive Announces First Commercial Cases Utilizing the Pulse Platform
SAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced Drs. Michael Kachmann and Zachary Tempel from Mayfield Brain & Spine in Ohio, and Dr. Paul Holman from Houston Methodist Hospital in Texas, completed the first commercial cases with the NuVasive Pulse® platform.
Sep 23, 2021 07:00 am ET
NuVasive Opens East Coast Experience Center in New York Metropolitan Area
SAN DIEGO, Sept. 23, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the opening of its East Coast Experience Center in the New York metropolitan area, expanding opportunities to train more surgeons and change more patient lives.
Sep 22, 2021 07:00 am ET
NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship
SAN DIEGO, Sept. 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its long-standing partnership with the Scoliosis Research Society (SRS) with a double diamond sponsorship and will attend the society's 56th Annual Meeting from September 22 to 25, 2021 in St. Louis, Mo.
Sep 09, 2021 07:00 am ET
NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery
SAN DIEGO, Sept. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify® Cervical Disc one-level U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study data was recently published in the International Journal of Spine Surgery. The data was utilized in the device's FDA pre-market application for one-level indication approval in September 2020.
Sep 09, 2021 06:00 am ET
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia to the Board of Directors
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021. “I am excited to join the...
Sep 01, 2021 04:10 pm ET
NuVasive Announces New Executive Leadership Roles
SAN DIEGO, Sept. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced new executive leadership roles, strengthening its innovation and go-to-market teams while furthering the Company's growth. Effective immediately, Massimo Calafiore has been appointed Chief Commercial Officer, and Ryan Donahoe has been appointed Chief Technology Officer, both reporting directly to Chief Executive Officer J. Christopher Barry.
Aug 30, 2021 07:00 am ET
NuVasive to Present at Upcoming Investor Conference
SAN DIEGO, Aug. 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will virtually present at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 9:30 a.m. PT / 12:30 p.m. ET.
Aug 09, 2021 04:10 pm ET
Amy Belt Raimundo to Join NuVasive Board of Directors
SAN DIEGO, Aug. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Amy Belt Raimundo to the Company's Board of Directors, effective August 9, 2021.
Jul 30, 2021 07:00 am ET
NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
SAN DIEGO, July 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that it received its latest U.S. Food and Drug Administration 510(k) clearance for the Pulse® platform, after receiving CE certification earlier this summer. In addition, the Company announced the commercial launch of Pulse which is now available for sale in targeted global regions.
Jul 28, 2021 04:10 pm ET
NuVasive Announces Second Quarter 2021 Financial Results
SAN DIEGO, July 28, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2021.
Jul 22, 2021 07:00 am ET
NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
SAN DIEGO, July 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the commercial launch of Modulus® ALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions.
Jul 14, 2021 04:10 pm ET
NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results
SAN DIEGO, July 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its second quarter 2021 earnings results on Wednesday, July 28, 2021, after the close of the market.
Jun 30, 2021 07:00 am ET
NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations
SAN DIEGO, June 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that the Pulse® platform received CE Mark approval for its latest design update and clinical evaluations are underway in multiple countries throughout Europe.
Feb 25, 2021 03:03 pm ET
NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results
SAN DIEGO, Feb. 25, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended Dec. 31, 2020.
Feb 24, 2021 03:03 pm ET
NuVasive Acquires Simplify Medical
SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it has acquired Simplify Medical, a privately held company and developer of the Simplify® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR).
Feb 18, 2021 07:33 am ET
NuVasive to Present at the 41st Annual Cowen Health Care Conference
SAN DIEGO, Feb. 18, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 41st Annual Cowen Health Care Conference on Monday, March 1, 2021 at 11:40 a.m. ET / 8:40 a.m. PT.
Feb 11, 2021 07:33 am ET
NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Results
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its fourth quarter and full year 2020 earnings results on Thursday, February 25, 2021, after the close of the market.
Feb 08, 2021 07:33 am ET
NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area
SAN DIEGO, Feb. 8, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the expansion of the Company's Clinical Professional Development (CPD) and surgeon education program with the planned opening of the NuVasive East Coast Experience Center in Englewood, New Jersey, in third quarter 2021. The East Coast Experience Center will complement the Company's West Coast Experience Center located at the NuVasive headquarters in San Diego, Calif
Feb 01, 2021 03:03 pm ET
Dr. Siddhartha Kadia to Join NuVasive Board of Directors
SAN DIEGO, Feb. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Siddhartha Kadia, Ph.D. to the Company's Board of Directors, effective February 1, 2021.
Jan 07, 2021 03:03 pm ET
NuVasive to Present at the 23rd Annual Needham Virtual Growth Conference
SAN DIEGO, Jan. 7, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 23rd Annual Needham Virtual Growth Conference on Thursday, January 14, 2021 at 1:15 p.m. ET/10:15 a.m. PT.
Jan 06, 2021 07:33 am ET
NuVasive's X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Leng
SAN DIEGO, Jan. 5, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, "Single position circumferential fusion improves operative efficiency, reduces complications and length of stay compared with traditional circumferential fusion," in The Spine Journal, validating single-position spine surgery as having significant advantages over traditional, open spinal fusion.
Jan 04, 2021 03:07 pm ET
NuVasive to Participate in 39th Annual Virtual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive Chief Executive Officer, J. Christopher Barry will present at the 39th Annual Virtual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 2:50 p.m. ET/ 11:50 a.m. PT.
Dec 07, 2020 07:33 am ET
NuVasive to Feature its C360 Portfolio at the Cervical Spine Research Society 48th Annual Meeting
SAN DIEGO, Dec. 7, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a silver level sponsor and feature its new C360™ cervical spine portfolio at the Cervical Spine Research Society (CSRS) 48th Annual Meeting held virtually from December 9-12, 2020.
Nov 30, 2020 07:33 am ET
NuVasive Unveils C360 Portfolio and Launches New Anterior Cervical Plate
SAN DIEGO, Nov. 30, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the unveiling of its new C360™ cervical spine portfolio, including the commercial launch of the Anterior Cervical Plating (ACP) system, featuring the thinnest plate on the market1 at 1.6 mm.
Nov 23, 2020 03:03 pm ET
NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
SAN DIEGO, Nov. 23, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in one-on-one investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2-3, 2020.
Nov 18, 2020 07:33 am ET
NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody
SAN DIEGO, Nov. 18, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Cohere® XLIF®, the first Porous PEEK™ interbody brought to market for use in eXtreme Lateral Interbody Fusion (XLIF) and X360™ surgeries. Cohere XLIF is a key addition to NuVasive's Advanced Materials Science™ (AMS) implant portfolio, consisting of proprietary surface and structural technologies, and is designed for bone in-growth while mai
Nov 09, 2020 07:33 am ET
NuVasive's Thoracolumbar Interbody Portfolio Receives First Clearance in the US for the Treatment of Sagittal Deformities
SAN DIEGO, Nov. 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thoracolumbar interbody portfolio to include the treatment of multi-level sagittal deformities of the thoracolumbar spine. This clearance expands the portfolio's indications from one- to two-level spine surgery, to now multiple levels, for the treatment of sagittal malalig
Nov 02, 2020 03:03 pm ET
NuVasive to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
SAN DIEGO, Nov. 2, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the Credit Suisse 29th Annual Virtual Healthcare Conference on Monday, November 9, 2020 at 11:00 a.m. ET/8:00 a.m. PT.
Oct 29, 2020 04:02 pm ET
NuVasive Announces Third Quarter 2020 Financial Results
SAN DIEGO, Oct. 29, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2020.
Oct 27, 2020 08:33 am ET
NuVasive to Participate as Gold Level Sponsor at SMISS Annual Forum
SAN DIEGO, Oct. 27, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold level sponsor at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum held virtually from October 29-31, 2020. NuVasive is also a committed platinum level sponsor of the annual forum for the proceeding three years, to further support the advancement of less invasive spine surgery.
Oct 19, 2020 04:03 pm ET
NuVasive Announces Conference Call and Webcast of Third Quarter 2020 Results
SAN DIEGO, Oct. 19, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2020 earnings results on Thursday, October 29, 2020 after the close of the market.
Oct 14, 2020 04:02 pm ET
NuVasive Announces New Organizational Structure to Align Global Commercial Operations and Product & Services Organization with Long-Term Strategy
SAN DIEGO, Oct. 14, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a new organizational and leadership structure for its global commercial operations as well as its product and services organization, which were previously consolidated under the role of the Company's president. The changes establish a new global commercial leader and bring together the Company's product and services teams under a single global leader. They
Aug 04, 2020 04:03 pm ET
NuVasive Announces Second Quarter 2020 Financial Results
SAN DIEGO, Aug. 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2020.
Jul 22, 2020 08:33 am ET
NuVasive's Less Invasive Procedural Solutions Are Clinically Proven to Reduce Operative Time and Improve Patient Outcomes in Spine Surgery
SAN DIEGO, July 22, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today launched its Time to Evolve campaign, calling surgeons to reconsider the way patient care is delivered in spine surgery by adopting NuVasive's less invasive approaches, best-in-class training and comprehensive procedural portfolio.
Jul 20, 2020 04:05 pm ET
NuVasive Announces Certain Preliminary Unaudited Second Quarter 2020 Results
SAN DIEGO, July 20, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced certain preliminary unaudited results for the second quarter 2020.
Jul 17, 2020 08:33 am ET
NuVasive Becomes First Industry Sponsor of the American Spine Registry to Improve Future of Spine Surgery Through Data-Driven Outcomes
SAN DIEGO, July 17, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the American Spine Registry™ (ASR), a national quality improvement registry for spine care, today announced that they have entered into a multi-year sponsorship to improve the future of spine surgery through data-driven outcomes. ASR is a collaboration between the American Association of Neurological Surgeons (AANS) and the American Academy of Orthopaedic Surgeons (AAOS) and t
Jun 18, 2020 08:33 am ET
NuVasive Expands Complex Spine Portfolio with Global Launch of Reline 3D for Pediatric Deformity
SAN DIEGO, June 18, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the expansion of its complex spine portfolio with the global commercial availability of Reline 3D™, a posterior fixation system for patients suffering from pediatric spinal deformities.
Jun 05, 2020 10:53 am ET
DLA Piper advises NuVasive in its US$400 million convertible senior notes offering
NEW YORK, June 5, 2020 /PRNewswire/ -- DLA Piper represented advised NuVasive, Inc. (NASDAQ: NUVA), a San Diego-based medical device company that creates and distributes products for surgical treatment of spine disorders, in its offering of US$400 million aggregate principal amount of 1.00% convertible senior notes due 2023. NuVasive also granted to the initial purchasers of the convertible notes a 13-day option to purchase up to an additional US$50 million principal amount of the notes.
Jun 04, 2020 04:10 pm ET
NuVasive, Inc. Announces Full Exercise Of Option By Initial Purchasers To Purchase Additional 1.00% Convertible Senior Notes Due 2023
SAN DIEGO, June 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today that it closed the issuance of an additional $50.0 million in aggregate principal amount of the 1.00% Convertible Senior Notes due 2023 (the "Convertible Notes"), pursuant to the exercise in full of the initial purchasers' option to purchase such additional notes (the "Option Notes") in connection with the previously announced Convertible Notes offering that closed on June 1, 2020.
May 28, 2020 12:18 am ET
NuVasive, Inc. Announces Pricing Of Offering Of $400 Million Of 1.00% Convertible Senior Notes Due 2023
SAN DIEGO, May 28, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering (the "Offering") of $400.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2023 (the "Convertible Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). NuVasive also granted to the initial purchasers of the Convertible Notes a 13-day option to purchase up to an additional $50.0 million aggregate principal amount of the Convertible Notes. The sale of the C
May 26, 2020 04:02 pm ET
NuVasive, Inc. Announces Proposed Offering Of $400 Million Of Convertible Senior Notes Due 2023
SAN DIEGO, May 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today that it intends to offer (the "Offering"), subject to market and other considerations, $400.0 million aggregate principal amount of Convertible Senior Notes due 2023 (the "Convertible Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). NuVasive also intends to grant to the initial purchasers of the Convertible Notes a 13-day option to purchase up to an additional $50.0 million aggregate principal amount o
May 19, 2020 08:33 am ET
NuVasive LessRay® Platform Wins Best New Imaging Technology Solution in 2020 MedTech Breakthrough Awards
SAN DIEGO, May 19, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform won the "Best New Imaging Technology Solution" award in the 2020 MedTech Breakthrough Awards.
May 12, 2020 04:03 pm ET
NuVasive to Participate in UBS Virtual Global Healthcare Conference
SAN DIEGO, May 12, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19 at 3:00 p.m. ET/12:00 p.m. PT.
May 06, 2020 04:02 pm ET
NuVasive Announces First Quarter 2020 Financial Results
SAN DIEGO, May 6, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2020.
May 05, 2020 08:33 am ET
NuVasive Expands Advanced Materials Science™ Implant Portfolio to Additional Thoracolumbar Procedures
SAN DIEGO, May 5, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the expansion of its Advanced Materials Science™ (AMS) implant portfolio with the commercial launch of the Modulus® XLIF® Dual Sided Plate, and the receipt of 510(k) clearances from the U.S. Food and Drug Administration (FDA) for Modulus ALIF and Cohere® TLIF-O.
May 04, 2020 04:03 pm ET
NuVasive to Participate in BofA Securities 2020 Healthcare Conference
SAN DIEGO, May 4, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the virtual BofA Securities 2020 Healthcare Conference on Tuesday, May 12 at 5:00 p.m. ET/2:00 p.m. PT.
Apr 14, 2020 04:02 pm ET
NuVasive Provides Business Update Related to COVID-19
SAN DIEGO, April 14, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today provided an update on actions the Company is taking to best position the business and support the Company's stakeholders in light of the COVID-19 pandemic.
Nov 14, 2019 07:33 am ET
NuVasive to Participate as Double Diamond Sponsor at the 13th International Congress on Early Onset Scoliosis and Host the MAGEC® Users Meeting
SAN DIEGO, Nov. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will participate as a double diamond sponsor at the 13th International Congress on Early Onset Scoliosis (ICEOS), November 21-22, 2019 at the Westin Peachtree Plaza in Atlanta. At the same location, on November 23, 2019, NuVasive will host the fourth annual MAGEC® Users Meeting.
Nov 13, 2019 07:33 am ET
NuVasive to Participate as Gold Sponsor at the Cervical Spine Research Society 47th Annual Meeting
SAN DIEGO, Nov. 13, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will participate as a gold sponsor at the Cervical Spine Research Society (CSRS) 47th Annual Meeting, November 21-23, 2019 at the New York Marriott Marquis in New York City.
Nov 04, 2019 03:03 pm ET
NuVasive to Present at the 28th Annual Credit Suisse Healthcare Conference
SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 28th Annual Credit Suisse Healthcare Conference at The Phoenician in Scottsdale, Arizona on Tuesday, November 12, 2019, at 1:50 p.m. MST/ 3:50 p.m. EST.
Oct 30, 2019 04:03 pm ET
NuVasive Announces Third Quarter 2019 Financial Results
SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2019.
Oct 14, 2019 04:07 pm ET
NuVasive Announces Conference Call and Webcast of Third Quarter 2019 Results
SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2019 earnings results on Wednesday, October 30, 2019 after the close of the market.
Oct 09, 2019 08:33 am ET
NuVasive to Participate as Gold Sponsor at the EUROSPINE 2019 Annual Meeting
SAN DIEGO, Oct. 9, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold sponsor at the EUROSPINE 2019 Annual Meeting held October 16-18, 2019 in Helsinki, Finland.
Sep 25, 2019 08:33 am ET
NuVasive to Demonstrate Enabling Technologies to Accelerate the Adoption of Less Invasive Spine Surgery at NASS 2019
SAN DIEGO, Sept. 25, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will highlight its enabling technologies at the North American Spine Society (NASS) Annual Meeting, September 25-28, 2019 at McCormick Place in Chicago.
Sep 23, 2019 04:03 pm ET
NuVasive LessRay® Platform Wins 2019 Spine Technology Award from Orthopedics This Week
SAN DIEGO, Sept. 23, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform won the 2019 Spine Technology Award presented by Orthopedics This Week, a widely read publication in the orthopedics industry. The Spine Technology Award recognizes the best new spine technologies, engineering teams and inventors for 2019 and rewards excellence in innovation.
Sep 11, 2019 08:33 am ET
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a double diamond sponsor at the Scoliosis Research Society (SRS) 54th Annual Meeting held September 18-21, 2019 in Montréal, Canada.
Sep 05, 2019 08:33 am ET
NuVasive Expands Cervical Advanced Materials Science™ Portfolio with Launch of Porous Titanium Implant
SAN DIEGO, Sept. 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® Cervical, a porous titanium interbody implant for cervical applications. The availability of Modulus Cervical expands the Company's Advanced Materials Science™ (AMS) portfolio to include both Porous PEEK™ and porous titanium offerings for anterior cervical discectomy and fusion (ACDF) techniques, a commonly performed surgery to add
Aug 28, 2019 08:33 am ET
NuVasive Announces Jerome Bettis, NFL Pro Football Hall of Famer, as Brand Ambassador
SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced Jerome Bettis, NFL Pro Football Hall of Famer and 2006 Super Bowl champion, will serve as a Company brand ambassador. The former Pittsburg Steelers running back will share his personal experience with NuVasive's XLIF® spine surgery to raise awareness about less invasive surgery, which has been linked to better outcomes for patients.
Aug 27, 2019 09:00 am ET
Alphatec Announces Favorable Judgment in NuVasive v. Miles Lawsuit
Alphatec Holdings, Inc. (“ATEC” or “the Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that the Delaware Chancery Court entered summary judgment in favor of its...
Aug 26, 2019 04:03 pm ET
NuVasive to Participate in Investor Events in September 2019
SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following investor events in September:
Aug 20, 2019 08:33 am ET
NuVasive Expands its Advanced Materials Science™ Portfolio to Offer Porous Titanium Spine Implants for all TLIF Procedures
SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-A, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This offering completes the Company's Advanced Materials Science™ (AMS) portfolio for all major posterior interbody fusion techniques used in TLIF, the most commonly performed procedure in the spine industry.
Aug 14, 2019 08:30 am ET
NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening
SAN DIEGO, Aug. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a milestone of 10,000 implants of the Precice® system for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™. The Precice system is an internal nail that once implanted, utilizes an External Remote Controller (ERC) to non-invasively lengthen the limb.
Aug 08, 2019 06:00 am ET
NuVasive Presents Long-Term Strategy and Financial Outlook at 2019 Investor Day
SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today is hosting its 2019 Investor Day in New York City with presentations by Chief Executive Officer J. Christopher Barry and other members of the management team.
Jul 30, 2019 04:02 pm ET
NuVasive Announces Second Quarter 2019 Financial Results
SAN DIEGO, July 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2019.
Jul 15, 2019 04:05 pm ET
NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results
SAN DIEGO, July 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its second quarter 2019 earnings results on Tuesday, July 30, 2019 after the close of the market.
Jul 15, 2019 08:30 am ET
Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced it has further strengthened and diversified its Board with the appointments of Peter Farrell,...
Jul 11, 2019 08:30 am ET
NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques
SAN DIEGO, July 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company is continuing its commitment to the Scoliosis Research Society as a Double Diamond sponsor of the 26th International Meeting on Advanced Spine Techniques (IMAST) being held July 17-20, 2019 at the RAI Amsterdam Convention Centre. NuVasive will highlight its leading solutions for adult and pediatric complex spine surgery and comprehensive approach to
Jul 10, 2019 08:30 am ET
NuVasive Launches Pulse™-The First Integrated Technology Platform to Enable Better Spine Surgery
SAN DIEGO, July 10, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of the Pulse™ integrated technology platform. Pulse is the first, single platform to include multiple technologies designed to help surgeons adopt more efficient, less disruptive surgical approaches in all spine procedures. Engineered to improve workflow, reduce variability and increase surgical reproducibility, Pulse addresses a broader range of clinica
May 14, 2019 08:30 am ET
NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting
SAN DIEGO, May 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company continues its commitment to the Society of Lateral Access Surgery (SOLAS) as a Global Partner, the leading sponsorship level in the partnership program, at the 12th annual SOLAS meeting being held May 16-18, 2019 in Miami, Florida. NuVasive will also participate in exhibit and workshop programs, featuring its comprehensive approach to lateral single-posi
May 06, 2019 04:05 pm ET
NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019
SAN DIEGO, May 6, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Bank of America Merrill Lynch Healthcare Conference 2019 at the Encore Hotel in Las Vegas on Wednesday, May 15, 2019, at 1:40 p.m. PT/4:40 p.m. ET.
May 01, 2019 04:02 pm ET
NuVasive Announces First Quarter 2019 Financial Results
SAN DIEGO, May 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2019.
Apr 22, 2019 08:30 am ET
Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK
SAN DIEGO, April 22, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study "Early Clinical Outcomes Comparing Porous PEEK, Smooth PEEK, and Structural Allograft Interbody Devices for Anterior Cervical Discectomy and Fusion," published online in the Journal of Spine & Neurosurgery, which concludes that the NuVasive proprietary Cohere® Porous polyetheretherketone (PEEK) implant demonstrates a clear benefit in p
Apr 15, 2019 04:05 pm ET
NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results
SAN DIEGO, April 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its first quarter 2019 earnings results on Wednesday, May 1, 2019 after the close of the market.
Apr 11, 2019 05:30 am ET
Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019
SAN DIEGO, April 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will introduce the X360™ system integrated with Pulse™ for lateral single-position surgery at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting being held April 13–17, 2019 in San Diego, California.
Apr 05, 2019 08:30 am ET
NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards
SAN DIEGO, April 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform was voted a gold winner in the advanced surgical instruments category at the 2019 Edison Awards™ held in New York City on April 4.
Apr 01, 2019 08:30 am ET
NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases
SAN DIEGO, April 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of Cohere® XLIF, the first-of-its-kind lateral Porous PEEK™ implant for XLIF® and lateral single-position surgery. The NuVasive Advanced Materials Science™ implant portfolio will remain on the forefront of innovation by incorporating Porous PEEK technology into its implants for lateral single-position surgery and beyond.
Mar 06, 2019 03:05 pm ET
NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019
SAN DIEGO, March 6, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its participation in and sponsorship of Spine Summit 2019 – 35th Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves, held March 14–17, 2019 at the Fountainebleau Miami Beach. NuVasive will facilitate surgeon education experiences at the summit through participation in a surgery lab featuring the latest advances in lateral single-po
Mar 06, 2019 07:55 am ET
Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook — Fundamental Analysis, Calculating Forward Movemen
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of E*TRADE Financial Corporation (NASDAQ:ETFC), Kennedy-Wilson Holdings...
Mar 05, 2019 03:05 pm ET
NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference
SAN DIEGO, March 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will present at the Cowen and Company 39th Annual Health Care Conference at The Boston Marriott Copley Place in Boston on Tuesday, March 12, 2019, at 9:20 a.m. ET / 6:20 a.m. PT.
Feb 21, 2019 03:05 pm ET
NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference
SAN DIEGO, Feb. 21, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will present at the 8th Annual Leerink Partners Global Healthcare Conference at the Lotte New York Palace Hotel in New York City on Thursday, Feb. 28, 2019 at 9 a.m. ET / 6 a.m. PT.
Feb 20, 2019 03:02 pm ET
NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results
SAN DIEGO, Feb. 20, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended Dec. 31, 2018.
Feb 19, 2019 07:30 am ET
NuVasive's Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System
SAN DIEGO, Feb. 19, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) – as well as European CE mark approval – for use of its Precice® Bone Transport System, the only all-internal system of its kind on the market indicated for use in segmental bone loss treatment in the tibia and femur resulting from trauma or infection. The Precice Bone Transport System jo
Feb 13, 2019 07:50 am ET
New Research: Key Drivers of Growth for Plains Group Holdings, Cooper Tire & Rubber, NuVasive, Envestnet, Pacific Ethanol, and Mistras Group — Factors of Influence, Major Initiatives and Sustained Pro
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Plains Group Holdings, L.P. (NYSE:PAGP), Cooper Tire & Rubber Company...
Feb 11, 2019 09:00 am ET
Alphatec Announces Stay of Court Proceedings in NuVasive Patent Lawsuit
Alphatec Holdings, Inc. (“ATEC” or “the Company”) (Nasdaq: ATEC) today announced several favorable developments in its ongoing patent litigation with NuVasive, Inc. (Nasdaq: NUVA). On February 6, 2019, the United States District Court for the...
Jan 29, 2019 03:05 pm ET
NuVasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2018 Results
SAN DIEGO, Jan. 29, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its fourth quarter and full year 2018 earnings results on Wednesday, Feb. 20, 2019 after the close of the market.
Jan 07, 2019 07:30 am ET
NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results
SAN DIEGO, Jan. 7, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced preliminary unaudited revenue results for the fourth quarter and full year 2018. The Company expects fourth quarter 2018 revenue to be approximately $288 million and full year 2018 revenue to be approximately $1,102 million.
Jan 03, 2019 07:30 am ET
NuVasive CEO J. Christopher Barry Announces New Organizational Structure And Leadership Team
SAN DIEGO, Jan. 3, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a new organizational structure and associated executive team that chief executive officer (CEO) J. Christopher (Chris) Barry has selected to lead the Company's next phase of growth and innovation. Barry joined NuVasive as CEO on November 5, 2018.
Dec 27, 2018 03:05 pm ET
NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 27, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will present at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Monday, Jan. 7, 2019, at 3:30 p.m. PT / 6:30 p.m. ET.
Dec 11, 2018 07:45 am ET
New Research Coverage Highlights Facebook, Korn/Ferry International, NuVasive, Sonic Automotive, B Communications, and Marin Software — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Facebook, Inc. (NASDAQ:FB), Korn/Ferry International (NYSE:KFY),...
Dec 10, 2018 07:30 am ET
NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant
SAN DIEGO, Dec. 10, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded use of its Monolith® Corpectomy System, providing surgeons with a modular PEEK interbody solution for cervical corpectomy procedures.
Nov 19, 2018 03:05 pm ET
NuVasive To Participate In The 30th Annual Piper Jaffray Healthcare Conference
SAN DIEGO, Nov. 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will be presenting at the Piper Jaffray 30th Annual Healthcare Conference at the Lotte New York Palace in New York City on Thursday, November 29, 2018 at 9:30 a.m. ET / 6:30 a.m. PT.
Nov 15, 2018 07:30 am ET
NuVasive Launches First-Of-Its-Kind Brigade® Lateral Implant And Instrumentation Optimized For Lateral Anterior Lumbar Interbody Fusion Spine Surgery
SAN DIEGO, Nov. 15, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the U.S. commercial launch of Brigade® Lateral, the industry's first interbody implant and instrumentation optimized for lateral anterior lumbar interbody fusion (ALIF) spine surgery.
Nov 08, 2018 03:05 pm ET
NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure
SAN DIEGO, Nov. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its COHERE® Porous PEEK™ implant in eXtreme Lateral Interbody Fusion (XLIF®) surgical spine procedures.
Nov 02, 2018 08:55 am ET
New Research: Key Drivers of Growth for Edison International, NuVasive, LogMein, Anika Therapeutics, First Industrial Realty Trust, and ON Semiconductor — Factors of Influence, Major Initiatives and S
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Edison International (NYSE:EIX), NuVasive, Inc. (NASDAQ:NUVA), LogMein,...
Oct 30, 2018 04:02 pm ET
NuVasive Reports Third Quarter 2018 Financial Results
SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended September 30, 2018.
Oct 19, 2018 08:30 am ET
NuVasive Names J. Christopher Barry To Succeed Gregory T. Lucier As Chief Executive Officer; Lucier To Remain Chairman Of The Board
SAN DIEGO, Oct. 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its Board of Directors has named J. Christopher Barry to succeed Gregory T. Lucier as chief executive officer (CEO) effective November 5, 2018. Mr. Barry will join the NuVasive Board of Directors; Mr. Lucier will continue to serve as chairman of the Board.
Oct 11, 2018 04:05 pm ET
NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results
SAN DIEGO, Oct. 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2018 earnings results on Tuesday, October 30, 2018 after the close of the market.
Oct 09, 2018 02:30 am ET
NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions
SAN DIEGO and DONAUESCHINGEN, GERMANY, Oct. 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has entered into a strategic partnership with Biedermann Technologies GmbH & Co. KG, a company that holds a broad and extensive patent and technology portfolio in the fields of spinal and extremity surgery, based in Donaueschingen, Germany.
Oct 08, 2018 08:30 am ET
NuVasive Clinical Services Awarded Sole Source Intraoperative Neuromonitoring Services Contract With Premier
SAN DIEGO, Oct. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive Clinical Services has been awarded a three-year, sole source supplier contract for Intraoperative Neuromonitoring (IONM) Services with Premier. Effective November 1, 2018, the new contract allows Premier members the option to take advantage of special pricing and terms pre-negotiated by Premier for IONM services provided by NuVasive Clinical Services (
Oct 04, 2018 04:05 pm ET
NuVasive To Showcase Comprehensive Solutions For Complex Spinal Deformities At Scoliosis Research Society Annual Meeting
SAN DIEGO, Oct. 4, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will highlight several of its latest spinal innovations to treat complex spinal deformities at the Scoliosis Research Society (SRS) Annual Meeting held October 10-13, 2018 in Bologna, Italy. As a Double Diamond Sponsor of SRS, NuVasive continues to demonstrate a strong leadership position in offering transformative solutions within the complex adult and pediatric
Oct 01, 2018 07:35 am ET
New Research Coverage Highlights Dillard's, AMC Entertainment, Patterson Companies, NuVasive, Life Storage, and Ambac Financial Group — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Dillard's, Inc. (NYSE:DDS), AMC Entertainment Holdings, Inc....
Sep 26, 2018 08:30 am ET
NuVasive Enrolls First Patients In Long-Term, Controlled Study Evaluating Advanced Implants' Effects On Fusion And Clinical Outcomes In XLIF® Procedures
SAN DIEGO, Sept. 26, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it enrolled its first patients in a prospective, multicenter study evaluating advanced spinal implants used in XLIF® procedures and their effect on long-term patient outcomes.
Sep 25, 2018 08:30 am ET
NuVasive To Demonstrate Pulse™ Surgical Automation Platform At NASS 2018 Annual Meeting
SAN DIEGO, Sept. 25, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that live demonstrations of the Pulse™ surgical automation platform with integration of the Siemens Healthineers' Cios Spin* cutting-edge mobile 3D-imaging will be held throughout the North American Spine Society (NASS) 2018 Annual Meeting, September 26-29, 2018.
Sep 24, 2018 08:30 am ET
NuVasive Expands Biologics Portfolio To Meet Clinical And Economic Needs
SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. commercial launch of three new biologics offerings to include traditional bone allograft, amniotic membrane DS and additional form factors to the current PropelTM DBM product line. This portfolio expansion demonstrates the Company's strategic efforts to deliver the most differentiated biologics portfolio in the spine industry.
Sep 21, 2018 08:30 am ET
Scott Huennekens To Join NuVasive Board Of Directors
SAN DIEGO, Sept. 21, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Scott Huennekens to the Company's Board of Directors, effective October 1, 2018.
Sep 20, 2018 08:30 am ET
NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018
SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will highlight the Company's latest disruptive spine technology at the North American Spine Society (NASS) Annual Meeting held September 26-29, 2018 in Los Angeles, California, at the Los Angeles Convention Center.
Sep 11, 2018 08:30 am ET
NuVasive Clinical Services™ Leader Richard Vogel Co-Chairs And Lectures At American Society Of Neurophysiological Monitoring 2018 Fall Symposium
SAN DIEGO, Sept. 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Richard Vogel, Ph.D., DABNM, FASNM, director of Strategic Initiatives at NuVasive Clinical ServicesTM (NCS), will co-chair, moderate and lecture at the American Society of Neurophysiological Monitoring (ASNM) 2018 Fall Symposium held September 15-16, 2018, in Nashville, Tennessee. ASNM is the largest professional society in the world dedicated to the advancement o
Sep 06, 2018 04:05 pm ET
NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference
SAN DIEGO, Sept. 6, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt New York in New York City on Wednesday, September 12, 2018, at 2:15 p.m. ET/11:15 a.m. PT.
Sep 05, 2018 08:30 am ET
NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant
SAN DIEGO, Sept. 5, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the launch of its TLX® 20 degree expandable spinal interbody implant with a first-of-its-kind oblique profile designed for transforaminal lumbar interbody fusion (TLIF) procedures. This product launch is another step forward in the Company's strategy to build a comprehensive expandable portfolio to best support optimal clinical outcomes.
Sep 04, 2018 04:02 pm ET
NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum
SAN DIEGO, Sept. 4, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will showcase industry-leading solutions for creating better clinical outcomes for spine procedures at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum being held September 6-8, 2018, in Las Vegas at Caesars Palace.
Aug 16, 2018 08:40 am ET
NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility
SAN DIEGO, Aug. 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Dale Wolf as vice president, Manufacturing, who will oversee the Company's West Carrollton, Ohio manufacturing facility.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.